US 7173039
Protein kinase inhibitors
granted A61PA61P17/06A61P19/02
Quick answer
US patent 7173039 (Protein kinase inhibitors) held by Theravance, Inc. expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P17/06, A61P19/02, A61P3/10